Harmony Biosciences Holdings, Inc.
HRMY
$28.46
$0.521.86%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 85.95% | 19.84% | -66.21% | 30.01% | -45.15% |
| Total Depreciation and Amortization | -2.56% | -2.26% | -0.20% | 0.99% | 0.94% |
| Total Amortization of Deferred Charges | -8.65% | -85.99% | -58.49% | -56.73% | -56.16% |
| Total Other Non-Cash Items | -65.85% | -37.85% | 1,072.09% | 139.48% | 249.93% |
| Change in Net Operating Assets | -50.02% | 73.96% | -105.03% | -643.21% | 199.57% |
| Cash from Operations | -1.44% | 11.73% | 14.99% | -26.83% | 187.37% |
| Capital Expenditure | -379.44% | -- | -208.29% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -761.45% | 192.00% | -179.61% | -245.31% | 102.15% |
| Cash from Investing | 80.07% | 191.64% | -605.91% | -245.59% | 23.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 98.09% | -650.00% | -650.00% | -650.00% |
| Issuance of Common Stock | 1,325.99% | 955.33% | -15.11% | -97.03% | -92.81% |
| Repurchase of Common Stock | 95.54% | 100.00% | 47.67% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 94.88% | 97.87% | -916.52% | -206.60% | -2,113.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 607.89% | 874.83% | -154.17% | -51.74% | 26.40% |